The effect of canakinumab on clinical outcomes in patients with COVID-19: A meta-analysis

J Infect. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.03.011. Epub 2022 Mar 14.

¹ Department of Nephrology, Chengdu First People's Hospital, Chengdu, Sichuan, China.
² Chengdu West China Clinical Research Center, Chengdu, Sichuan, China.
³ School of Medicine, Queen's University, Kingston, Canada.
⁴ Schulich School of Medicine and Dentistry, Western University, London, Canada.
⁵ Department of Cardiology, West China Hospital, Sichuan University, No.37 Guoxue Lane, Wuhou District, Chengdu, Sichuan 610044, China. Electronic address: qingyang@scu.edu.cn.

No abstract available

Keywords: COVID-19; Canakinumab; Mortality; SARS-CoV-2.

Publication types